tiprankstipranks
Trending News
More News >
ImmunoCellular Therapeutics (IMUC)
OTHER OTC:IMUC
US Market

Compare ImmunoCellular Therapeutics (IMUC) vs. Competitors

Compare
186 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
ImmunoCellular Therapeutics
$0.16
$18.11M
2.58%
Xenetic Biosciences
$2.21
$7.17M
-1.38
-7.12%
Adial Pharmaceuticals
$0.22
$2.63M
-0.46
-90.03%
1 Buy
0 Hold
0 Sell
Moderate Buy
VYNE Therapeutics
$0.58
$20.48M
-0.94
-64.30%
IN8bio
$1.66
$16.35M
-0.53
-76.22%
3 Buy
0 Hold
0 Sell
Strong Buy
Bolt Biotherapeutics
$4.38
$8.42M
-0.31
-50.11%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMUC
ImmunoCellular Therapeutics
0.16
<0.01
2.58%
XBIO
Xenetic Biosciences
3.13
-0.25
-7.40%
ADIL
Adial Pharmaceuticals
1.84
-15.91
-89.63%
VYNE
VYNE Therapeutics
0.61
-1.14
-64.91%
INAB
IN8bio
1.66
-5.18
-75.72%
BOLT
Bolt Biotherapeutics
4.38
-4.37
-49.94%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts